noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

American Heart Association

Discontinuing statins generally safe for older adults without heart disease
American Heart Association

Selective smartphone alerts helped improve bystander response time for[...]
American Heart Association

Can a low-cost diuretic medication help to lower blood pressure after a[...]

Healthcare

Altimmune Inc.

11/07/2026 | Press release | Distributed by Public on 11/07/2026 14:17

Poster: Gastrointestinal Tolerability of Pemvidutide Without Dose Titration in Patients with Metabolic Dysfunction-Associated Steatohepatitis from the Phase 2b IMPACT Trial

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Altimmune Inc. published this content on November 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 07, 2026 at 20:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]